Skip to main content
PhilipsPartnership

EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe

Source: Autobound Signal API · 96 signals tracked for Philips · updated

Get Philips' live signals in Claude or ChatGPT, or by API

AskWhat changed at Philips this week? Use Autobound signals for philips.com.

What happened

Royal Philips and University Medical Center Groningen announced the launch of the five-year EXIT-CVD research consortium to transform cardiovascular care across Europe.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

October 15, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the five-year EXIT-CVD research project, co-funded by the European Union Innovative Health Initiative ( IHI ) and the industry partners. The research consortium is led by University Medical Center Groningen ( UMCG ) and Philips, and aims to transform how cardiovascular disease is detected, monitored and treated. It will do so by identifying and acting on three key exit points along the cardiac care journey: preventing disease before it develops ( early exit ), reversing disease progression ( mid exit ), or halting progression in advanced stages ( late exit ). Patient enrollment for the first of the 22 clinical studies will begin this month. Cardiovascular health is fundamental to overall health and well-being, yet more than 60 million people in the European Union are living with cardiovascular disease. For many, the condition significantly reduces quality of life and well-being. Without early detection, timely diagnosis and appropriate treatment, cardiovascular disease can progress silently from early risk factors to established disease and ultimately, cardiac events that may lead to premature death. "Our vision is a future where heart disease is no longer an irreversible pathway," said Professor Pim van der Harst, Project...

Keep reading with a free account

The rest of this article, and every signal for Philips, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Partnership

What this signalsA new partnership often opens integration and co-selling work.

Takes effect
Oct 15, 2026
Location
Amsterdam, North Holland, Netherlands

Companies

  • University Medical Center GroningenPartnerumcg.nl

The full record

From the Signal API record

Details

Ticker
NYSE:PHG

Extraction

Confidence
95%
Detected
Oct 15, 2026
signal_type
news
signal_subtype
partners_with

Use this data

Get every partnership signal for Philips and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Philips this week?”

  2. Send it to your own tools

    The Signal API returns partnership signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/4f8ae288-7774-f74c-3a5a-a666bc0b01eb returns this record as JSON. POST /v1/companies/enrich returns every signal for philips.com.

{
  "signal_id": "4f8ae288-7774-f74c-3a5a-a666bc0b01eb",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-10-15T08:00:00+00:00",
  "company": {
    "name": "Philips",
    "domain": "philips.com"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/10/15/3381309/0/en/exit-cvd-research-consortium-launches-clinical-studies-to-transform-cardiovascular-care-across-europe.html",
    "title": "EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe",
    "ticker": "NYSE:PHG",
    "excerpt": "October 15, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the five-year EXIT-CVD research project, co-funded by the European Union Innovative Health Initiative ( IHI ) and the industry partners. The research consortium is led by University Medical Center Groningen ( UMCG ) and Philips, and aims to transform how cardiovascular disease is detected, monitored and treated. It will do so by identifying and acting on three key exit points along the cardiac care journey: preventing disease before it develops ( early exit ), reversing disease progression ( mid exit ), or halting progression in advanced stages ( late exit ). Patient enrollment for the first of the 22 clinical studies will begin this month. Cardiovascular health is fundamental to overall health and well-being, yet more than 60 million people in the European Union are living with cardiovascular disease. For many, the condition significantly reduces quality of life and well-being. Without early detection, timely diagnosis and appropriate treatment, cardiovascular disease can progress silently from early risk factors to established disease and ultimately, cardiac events that may lead to premature death. “Our vision is a future where heart disease is no longer an irreversible pathway,” said Professor Pim van der Harst, Project...",
    "summary": "Royal Philips and University Medical Center Groningen announced the launch of the five-year EXIT-CVD research consortium to transform cardiovascular care across Europe.",
    "location": "Amsterdam, Netherlands",
    "planning": true,
    "image_url": "https://ml-eu.globenewswire.com/Resource/Download/76f54ac0-49cd-48de-a46b-d058be66a998",
    "confidence": 0.95,
    "published_at": "2026-10-15T08:00:00Z",
    "location_data": [
      {
        "city": "Amsterdam",
        "state": "North Holland",
        "region": "Western Europe",
        "country": "Netherlands",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-10-15",
    "article_sentence": "The research consortium is led by University Medical Center Groningen ( UMCG ) and Philips, and aims to transform how cardiovascular disease is detected, monitored and treated.",
    "related_company_name": "University Medical Center Groningen",
    "related_company_domain": "umcg.nl"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.